8-K - Agilon Health, Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

On February 12, 2026, agilon health, inc. entered into a Third Amendment to its Credit Agreement, extending the maturity date to February 18, 2028 and reducing revolving credit commitments to $90.0 million. The amendment imposes a $50 million daily minimum cash requirement and mandates cash collateralization of outstanding letters of credit at 103%.

Key Takeaways

1The Credit Agreement maturity date was extended by two years, from February 18, 2026 to February 18, 2028.

2Revolving credit commitments were reduced from $100.0 million to $90.0 million.

3The Company must maintain a minimum of $50 million in Total Cash at the end of each Business Day.

4Outstanding letters of credit must be cash collateralized at 103% of the amount outstanding immediately prior to the Third Amendment Effective Date.

5agilon health, inc. executed an unsecured Parent Guaranty of the Borrower's obligations under the Credit Agreement.

6Dividends and certain payments are now conditioned on the Company achieving positive EBITDA for two consecutive trailing four-quarter periods.

Current Report Details

Event Type

Material Agreement

Financing

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

Entry into a Material Definitive Agreement. On February 12, 2026 (the “Third Amendment Effective Date”), agilon health, inc. (the "Company"), agilon health mana

Material Agreement

$50.0M$100.0M$90.0M

Source Document

2.03

. Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 10.1 Third Amendment to Credit Agreement, dated as of February 12, 2026,

Financing

Transaction Details

Material Agreement

Agreement: Third Amendment to Credit Agreement
Parties: agilon health, inc., agilon health management, inc., Agilon Health Intermediate Holdings, Inc., J.P. Morgan Chase Bank, N.A.

•Extended the stated maturity date from February 18, 2026 to February 18, 2028
•Reduced the aggregate amount of revolving credit commitments from $100.0 million to $90.0 million
•Required that Management maintain a minimum of $50 million in Total Cash as of the end of each Business Day
•Required cash collateralization at 103% of the amount of each letter of credit outstanding immediately prior to the Third Amendment Effective Date
•Amended certain covenant baskets to be measured as a percentage of EBITDA
•Conditioned certain payments, including dividends, on achieving positive EBITDA for two consecutive trailing four-quarter periods
•Required that any reduction in outstanding letters of credit be accompanied by a corresponding prepayment of term loans

Debt / Financing

Instrument: Credit Agreement
Maturity: 2028-02-18

Exhibits (3)

10.1

EX-10.1

10.2

EX-10.2

8-K